DZ3156A1 - Nouvelle forme polymorphe du sel d'acide 5-Ä4-Ä2-(n-methyl-n-(2-pyridyl)amino)ethoxyÜbenzylÜthiazolidine-2,4-dione, maleique. - Google Patents

Nouvelle forme polymorphe du sel d'acide 5-Ä4-Ä2-(n-methyl-n-(2-pyridyl)amino)ethoxyÜbenzylÜthiazolidine-2,4-dione, maleique.

Info

Publication number: DZ3156A1
Authority: DZ; Algeria
Prior art keywords: ethoxyübenzylüthiazolidine; dione; pyridyl; amino; methyl
Prior art date: 1999-04-23

Application number

DZ003156A

Other languages

English (en)

Inventor

Paul David James Blackler

Christine Marie Browne

Timothy G Coakley

Robert Gordon Giles

Gillian Morrissey

Original Assignee

Smithkline Beecham Plc

Smithkline Beecham Cork Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-23

Filing date

2000-04-19

Publication date

2000-11-02

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26315461&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ3156(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-04-23 Priority claimed from GBGB9909473.2A external-priority patent/GB9909473D0/en

1999-05-25 Priority claimed from GBGB9912196.4A external-priority patent/GB9912196D0/en

2000-04-19 Application filed by Smithkline Beecham Plc, Smithkline Beecham Cork Ltd filed Critical Smithkline Beecham Plc

2000-11-02 Application granted granted Critical

2000-11-02 Publication of DZ3156A1 publication Critical patent/DZ3156A1/fr

Links

OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 title 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 title 1
239000011976 maleic acid Substances 0.000 title 1
150000003839 salts Chemical class 0.000 title 1
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Diabetes (AREA)
General Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Hematology (AREA)
Obesity (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

DZ003156A 1999-04-23 2000-04-19 Nouvelle forme polymorphe du sel d'acide 5-Ä4-Ä2-(n-methyl-n-(2-pyridyl)amino)ethoxyÜbenzylÜthiazolidine-2,4-dione, maleique. DZ3156A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9909473.2A GB9909473D0 (en)	1999-04-23	1999-04-23	Novel compounds
GBGB9912196.4A GB9912196D0 (en)	1999-05-25	1999-05-25	Novel pharmaceutical
PCT/GB2000/001520 WO2000064896A1 (fr)	1999-04-23	2000-04-19	Nouvelle forme polymorphe du sel d'acide 5-[4-[2- (n-methyl-n-( 2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2, 4-dione,maleique

Publications (1)

Publication Number	Publication Date
DZ3156A1 true DZ3156A1 (fr)	2000-11-02

Family

ID=26315461

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ003156A DZ3156A1 (fr)	1999-04-23	2000-04-19	Nouvelle forme polymorphe du sel d'acide 5-Ä4-Ä2-(n-methyl-n-(2-pyridyl)amino)ethoxyÜbenzylÜthiazolidine-2,4-dione, maleique.

Country Status (40)

Country	Link
US (2)	US6806280B1 (fr)
EP (2)	EP1304330A3 (fr)
JP (1)	JP2002543077A (fr)
KR (1)	KR100744360B1 (fr)
CN (1)	CN1167702C (fr)
AP (1)	AP1598A (fr)
AR (2)	AR023561A1 (fr)
AT (1)	ATE246191T1 (fr)
AU (1)	AU765005B2 (fr)
BG (1)	BG65485B1 (fr)
BR (1)	BR0009932A (fr)
CA (1)	CA2370280A1 (fr)
CO (1)	CO5170421A1 (fr)
CZ (1)	CZ20013800A3 (fr)
DE (1)	DE60004196T2 (fr)
DK (1)	DK1173435T3 (fr)
DZ (1)	DZ3156A1 (fr)
EA (1)	EA004541B1 (fr)
ES (1)	ES2203453T3 (fr)
HK (1)	HK1045153B (fr)
HR (1)	HRP20010772B1 (fr)
HU (1)	HUP0200931A3 (fr)
IL (1)	IL146111A0 (fr)
MA (1)	MA25356A1 (fr)
MX (1)	MXPA01010821A (fr)
MY (1)	MY131973A (fr)
NO (1)	NO320574B1 (fr)
NZ (1)	NZ515168A (fr)
OA (1)	OA11872A (fr)
PE (1)	PE20010044A1 (fr)
PL (1)	PL351684A1 (fr)
PT (1)	PT1173435E (fr)
SK (1)	SK286427B6 (fr)
TR (1)	TR200103062T2 (fr)
TW (1)	TWI283677B (fr)
UA (1)	UA67844C2 (fr)
UY (1)	UY26121A1 (fr)
WO (1)	WO2000064896A1 (fr)
YU (1)	YU75301A (fr)
ZA (1)	ZA200108719B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6664278B2 (en)	1997-12-16	2003-12-16	Smithkline Beecham P.L.C.	Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
GB9726568D0 (en)	1997-12-16	1998-02-11	Smithkline Beecham Plc	Novel pharmaceutical
US20020137940A1 (en) *	1997-12-16	2002-09-26	Smithkline Beecham P.L.C.	5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
AR023561A1 (es) *	1999-04-23	2002-09-04	Smithkline Beecham Corp	Una forma polimorfica del acido maleico de un derivado de tiazolidin-2, 4 diona, una composicion farmaceutica y el uso de dicho polimorfo para lafabricacion de un medicamento
US20040248945A1 (en)	1999-04-23	2004-12-09	Smithkline Beecham P.L.C.	Thiazolidinedione derivative and its use as antidiabetic
HRP20010773B1 (en)	1999-04-23	2005-06-30	Smithkline Beecham P.L.C.	Thiazolidinedione derivative and its use as antidiabetic
GB0006133D0 (en)	2000-03-14	2000-05-03	Smithkline Beecham Plc	Novel pharmaceutical
US7241895B2 (en)	2000-09-26	2007-07-10	Dr. Reddy's Laboratories Limited	Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino[ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
CA2426117A1 (fr) *	2000-09-26	2002-04-04	Dr. Reddy's Laboratories Limited	Nouvelles formes polymorphes de 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate et procede de preparation associe
CA2484460C (fr) *	2002-04-19	2009-09-29	Faes Farma, S.A.	Polymorphe de l'acide 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl]ethyl]-.alpha..alpha. dimethyl-benzeneacetique
GB0307259D0 (en) *	2003-03-28	2003-05-07	Glaxo Group Ltd	Process
EP1468997A3 (fr) *	2003-04-18	2004-11-03	CHEMI S.p.A.	Formes polymorphes de maléate de rosiglitatone
GB2405403A (en) *	2003-08-29	2005-03-02	Cipla Ltd	Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
EP1709038A2 (fr) *	2004-01-28	2006-10-11	Usv Limited	Procede de preparation de maleate de 5- 4- 2- n-methyl-n-(2-pyridyl) amino¨ ethoxy¨ phenyl methyl¨ thiazolidine-2, 4-dione
ITMI20041537A1 (it) *	2004-07-28	2004-10-28	Chemi Spa	Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) *	2005-05-24	2007-09-26	Zentiva, A. S.	Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
US20090076093A1 (en) *	2007-09-14	2009-03-19	Protia, Llc	Deuterium-enriched rosiglitazone
EP2184055A1 (fr)	2008-11-07	2010-05-12	LEK Pharmaceuticals d.d.	Procédé de préparation de formes galéniques solides de maléate de rosiglitazone
JP2010013472A (ja) *	2009-09-09	2010-01-21	Faes Farma Sa	４−［２−［１−（２−エトキシエチル）−１Ｈ−ベンズイミダゾール−２−イル］−１−ピペリジニル］エチル］−α，α−ジメチルベンゼノ酢酸の多形体
MX2022004474A (es)	2016-12-16	2023-08-15	Janssen Pharmaceutica Nv	Inhibidores de moléculas pequeñas de la familia de quinasas jak.
JOP20190144A1 (ar)	2016-12-16	2019-06-16	Janssen Pharmaceutica Nv	إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
TW202016110A (zh)	2018-06-15	2020-05-01	比利時商健生藥品公司	Ｊａｋ激酶家族之小分子抑制劑
US12390451B2 (en)	2021-03-11	2025-08-19	Janssen Pharmaceutica Nv	Small molecule inhibitor of the JAK family of kinases

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE186724T1 (de)	1987-09-04	1999-12-15	Beecham Group Plc	Substituierte thiazolidindionderivate
GB9124513D0 (en)	1991-11-19	1992-01-08	Smithkline Beecham Plc	Novel process
US6462337B1 (en) *	2000-04-20	2002-10-08	Agilent Technologies, Inc.	Mass spectrometer electrospray ionization
GB9218830D0 (en)	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
US5741803A (en)	1992-09-05	1998-04-21	Smithkline Beecham Plc	Substituted thiazolidinedionle derivatives
US5457109A (en) *	1993-09-15	1995-10-10	Warner-Lambert Company	Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
DE4404198A1 (de)	1994-02-10	1995-08-17	Henkel Kgaa	2-Fluor-6-nitroaniline
UY24886A1 (es) *	1997-02-18	2001-08-27	Smithkline Beecham Plc	Tiazolidindiona
US6632947B2 (en) *	1997-02-18	2003-10-14	Smithkline Beecham Plc	Process for the preparation of substituted thiazolidinedione
GB9711683D0 (en) *	1997-06-05	1997-08-06	Smithkline Beecham Plc	Composition
US7091359B2 (en) *	1997-11-04	2006-08-15	Smithkline Beecham Plc	Process for the preparation of thiazolidinedione derivatives
US6664278B2 (en)	1997-12-16	2003-12-16	Smithkline Beecham P.L.C.	Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
GB9726563D0 (en)	1997-12-16	1998-02-11	Smithkline Beecham Plc	Novel pharmaceutical
US20020137940A1 (en)	1997-12-16	2002-09-26	Smithkline Beecham P.L.C.	5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
GB9726566D0 (en) *	1997-12-16	1998-02-11	Smithkline Beecham Plc	Novel pharmaceutical
US6613785B2 (en) *	1998-07-21	2003-09-02	Smithkline Beecham Plc	Use of glucose uptake enhancer for reducing post-ischemic injury of the heart
AR023561A1 (es) *	1999-04-23	2002-09-04	Smithkline Beecham Corp	Una forma polimorfica del acido maleico de un derivado de tiazolidin-2, 4 diona, una composicion farmaceutica y el uso de dicho polimorfo para lafabricacion de un medicamento
CZ20013801A3 (cs)	1999-04-23	2002-07-17	Smithkline Beecham Plc	Nový léčivý přípravek
HRP20010773B1 (en) *	1999-04-23	2005-06-30	Smithkline Beecham P.L.C.	Thiazolidinedione derivative and its use as antidiabetic
CN1277965A (zh)	2000-06-14	2000-12-27	中国医药研究开发中心	盐酸罗格列酮及其应用
CA2426117A1 (fr)	2000-09-26	2002-04-04	Dr. Reddy's Laboratories Limited	Nouvelles formes polymorphes de 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate et procede de preparation associe

2000
- 2000-04-19 AR ARP000101862A patent/AR023561A1/es unknown
- 2000-04-19 EA EA200101121A patent/EA004541B1/ru not_active IP Right Cessation
- 2000-04-19 JP JP2000614248A patent/JP2002543077A/ja active Pending
- 2000-04-19 EP EP02080321A patent/EP1304330A3/fr not_active Withdrawn
- 2000-04-19 SK SK1492-2001A patent/SK286427B6/sk not_active IP Right Cessation
- 2000-04-19 DK DK00920892T patent/DK1173435T3/da active
- 2000-04-19 US US10/048,123 patent/US6806280B1/en not_active Expired - Fee Related
- 2000-04-19 PT PT00920892T patent/PT1173435E/pt unknown
- 2000-04-19 OA OA1200100276A patent/OA11872A/en unknown
- 2000-04-19 ES ES00920892T patent/ES2203453T3/es not_active Expired - Lifetime
- 2000-04-19 PE PE2000000365A patent/PE20010044A1/es not_active Application Discontinuation
- 2000-04-19 AU AU41308/00A patent/AU765005B2/en not_active Ceased
- 2000-04-19 CN CNB008091463A patent/CN1167702C/zh not_active Expired - Fee Related
- 2000-04-19 UA UA2001117939A patent/UA67844C2/uk unknown
- 2000-04-19 PL PL00351684A patent/PL351684A1/xx not_active Application Discontinuation
- 2000-04-19 BR BR0009932-5A patent/BR0009932A/pt not_active Application Discontinuation
- 2000-04-19 CZ CZ20013800A patent/CZ20013800A3/cs unknown
- 2000-04-19 DZ DZ003156A patent/DZ3156A1/fr active
- 2000-04-19 NZ NZ515168A patent/NZ515168A/xx unknown
- 2000-04-19 CO CO00028929A patent/CO5170421A1/es not_active Application Discontinuation
- 2000-04-19 DE DE60004196T patent/DE60004196T2/de not_active Expired - Fee Related
- 2000-04-19 IL IL14611100A patent/IL146111A0/xx unknown
- 2000-04-19 EP EP00920892A patent/EP1173435B1/fr not_active Expired - Lifetime
- 2000-04-19 HK HK02104879.6A patent/HK1045153B/en not_active IP Right Cessation
- 2000-04-19 HR HR20010772A patent/HRP20010772B1/xx not_active IP Right Cessation
- 2000-04-19 AP APAP/P/2001/002330A patent/AP1598A/en active
- 2000-04-19 CA CA002370280A patent/CA2370280A1/fr not_active Abandoned
- 2000-04-19 MX MXPA01010821A patent/MXPA01010821A/es active IP Right Grant
- 2000-04-19 YU YU75301A patent/YU75301A/sh unknown
- 2000-04-19 KR KR1020017013540A patent/KR100744360B1/ko not_active Expired - Fee Related
- 2000-04-19 TR TR2001/03062T patent/TR200103062T2/xx unknown
- 2000-04-19 AR ARP000101867A patent/AR023565A1/es unknown
- 2000-04-19 AT AT00920892T patent/ATE246191T1/de not_active IP Right Cessation
- 2000-04-19 WO PCT/GB2000/001520 patent/WO2000064896A1/fr not_active Ceased
- 2000-04-19 HU HU0200931A patent/HUP0200931A3/hu unknown
- 2000-04-21 MY MYPI20001708A patent/MY131973A/en unknown
- 2000-04-24 UY UY26121A patent/UY26121A1/es not_active Application Discontinuation
- 2000-05-11 TW TW089108962A patent/TWI283677B/zh not_active IP Right Cessation
2001
- 2001-10-22 NO NO20015147A patent/NO320574B1/no unknown
- 2001-10-22 MA MA26378A patent/MA25356A1/fr unknown
- 2001-10-23 ZA ZA200108719A patent/ZA200108719B/en unknown
- 2001-11-20 BG BG106121A patent/BG65485B1/bg unknown
2004
- 2004-09-08 US US10/935,939 patent/US20050080114A1/en not_active Abandoned

Also Published As

Publication number	Publication date
BG106121A (en)	2002-05-31
HRP20010772A2 (en)	2002-10-31
UA67844C2 (uk)	2004-07-15
BR0009932A (pt)	2002-04-09
EP1173435B1 (fr)	2003-07-30
PL351684A1 (en)	2003-06-02
AP2001002330A0 (en)	2000-12-31
CZ20013800A3 (cs)	2002-04-17
MA25356A1 (fr)	2001-12-31
CN1167702C (zh)	2004-09-22
IL146111A0 (en)	2002-07-25
AU4130800A (en)	2000-11-10
CN1356999A (zh)	2002-07-03
NO20015147D0 (no)	2001-10-22
US20050080114A1 (en)	2005-04-14
PE20010044A1 (es)	2001-03-10
EP1304330A2 (fr)	2003-04-23
KR100744360B1 (ko)	2007-07-30
EA004541B1 (ru)	2004-06-24
DE60004196T2 (de)	2004-04-15
ES2203453T3 (es)	2004-04-16
ZA200108719B (en)	2002-06-21
NZ515168A (en)	2004-02-27
NO320574B1 (no)	2005-12-27
KR20010110797A (ko)	2001-12-13
CO5170421A1 (es)	2002-06-27
JP2002543077A (ja)	2002-12-17
AP1598A (en)	2006-04-26
WO2000064896A1 (fr)	2000-11-02
SK14922001A3 (sk)	2002-02-05
BG65485B1 (bg)	2008-09-30
TWI283677B (en)	2007-07-11
MY131973A (en)	2007-09-28
UY26121A1 (es)	2000-12-29
YU75301A (sh)	2004-07-15
EP1173435A1 (fr)	2002-01-23
HUP0200931A3 (en)	2004-03-29
HK1045153B (en)	2004-07-09
MXPA01010821A (es)	2003-09-04
AU765005B2 (en)	2003-09-04
PT1173435E (pt)	2003-12-31
WO2000064896A9 (fr)	2001-10-25
OA11872A (en)	2006-03-27
NO20015147L (no)	2001-12-17
HRP20010772B1 (hr)	2007-05-31
EP1304330A3 (fr)	2003-11-19
EA200101121A1 (ru)	2002-04-25
DK1173435T3 (da)	2003-11-24
SK286427B6 (sk)	2008-09-05
US6806280B1 (en)	2004-10-19
TR200103062T2 (tr)	2002-05-21
HK1045153A1 (en)	2002-11-15
CA2370280A1 (fr)	2000-11-02
HUP0200931A2 (en)	2002-08-28
AR023561A1 (es)	2002-09-04
DE60004196D1 (de)	2003-09-04
ATE246191T1 (de)	2003-08-15
AR023565A1 (es)	2002-09-04

Publication	Publication Date	Title
MA25356A1 (fr)	2001-12-31	Polymorphe du sel de l'acide maleique 5-(4-(2-n-methyl-n(2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2,4-dione.
ATE249462T1 (de)	2003-09-15	Neue kristalline form von n-(4-(2-(2-amino-4,7- dihydro-4-oxo-3h-pyrrolo(2,3-d)-pyrimidin-5- yl)ethyl)benzoyl)-l-glutaminsäure und verfahren für ihre herstellung
EP1569943A4 (fr)	2007-11-28	Procede pour la preparation de chelate d'acide amine
MA25658A1 (fr)	2002-12-31	Sels hydrochlores de 5(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thyazolidine-2,4-dione.
DZ3001A1 (fr)	2004-03-27	Sel de potassium d'oméprazole-(S).
CY1107238T1 (el)	2012-11-21	Παρασκευη μιας πολυμορφικης μορφης ενος παραγωγου θειαζολιδινοδιονης
WO2000023407A3 (fr)	2000-08-03	Composes chimiques
DZ2448A1 (fr)	2003-01-11	Sel du dérivé d'acide de naphthyridine carboxylique.
DZ2681A1 (fr)	2004-06-20	Forme nouvelle d'hydrate de sel d'acide maléique de 5-Ä4-Ä2-(n-methyl-n(2-pyridyl)amino)ethoxyÜbenzylÜ-thiazololidine-2,4-dione et composition pharmaceutique la contenant.
RU97115863A (ru)	1998-12-10	Иммуномодулирующее средство
WO2000076489A3 (fr)	2002-05-30	Procede d'inhibition de l'agregation de proteines amyloides et de formation d'images de depots amyloides
NO20003068D0 (no)	2000-06-15	Hydrat av 5-[-4-[2-(N-metyl-N-(2- pyridyl)amino)etoksy]benzyl]tiazolidin-2,4-dion-maleinsyre-salt
MA26844A1 (fr)	2004-12-20	Nouveaux derives de la thiazolidinedione comme agents antidiabetiques
DE60222806D1 (de)	2007-11-15	Verfahren zur herstellung von (1,4,5)-oxadiazepinderivaten
DK1177166T3 (da)	2008-06-16	Fremgangsmåde til fremstilling af (1R,2S,4R)-(-)-2(2'-N,N-dimenthylamino-etoxy)-2-phenyl-1,7,7-tri-mehtyl.bicyclo-2.2.1-heptan og farmaceutisk acceptable syreadditionssalte deraf
NO20000456L (no)	2000-08-07	FremgangsmÕte for fremstilling av 1,2-dikloretan
DK1373232T3 (da)	2006-03-27	Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner
MXPA03006606A (es)	2003-09-22	Proceso para preparacion de analogos de indeno heterociclico.
NO20021727L (no)	2002-04-12	Fremgangsmåte for fremstilling av 3,4-metylen-dioksy- mandelisk syre
DK1413575T3 (da)	2006-12-27	Fremgangsmåde til fremstilling af derivater af (1,5-diaryl)pyrazol-3-ylpropansyre
MA25412A1 (fr)	2002-04-01	Procede pour la preparation d'acides 2-(n-phenylamino) benzoiques.
DE60000274D1 (de)	2002-08-29	Verfahren zur Herstelung von Pirlindolehydrochlorid
NO20014059D0 (no)	2001-08-21	Krystallmodifikasjon D av 8-cyano-1-cyklopropyl-7-(1S,6S-2,8- diazabicyklo-/4.3.0/-nonan-8-yl)-6-fluor-1,4-dihydro-4-okso-3-kinolinkarboksylsyre
WO2002008247A3 (fr)	2002-10-17	Procede chimique
MA25830A1 (fr)	2003-07-01	Sel de tartrate d'un derive de thiazolidinedione.